Skip to main navigation Skip to search Skip to main content

Visual and Quantitative Analysis of 123I-Ioflupane SPECT Reveals Asymmetric Neuronal Degeneration in Fahr’s Disease

  • Seda Gülbahar Ateş*
  • , Uğuray Aydos
  • , Erdem Balci
  • , Ümit Özgür Akdemir
  • , Lütfiye Özlem Atay
  • *Corresponding author for this work
  • Gazi University

Research output: Contribution to journalArticlepeer-review

Abstract

Fahr’s disease is a rare disorder characterized by bilateral and symmetric calcifications in brain structures, including the basal ganglia, cerebellum, thalamus, and cerebral white matter. The findings of 123I-Ioflupane SPECT in Fahr’s disease have only been reported in a limited number of case reports. We present the case of a 64-year-old woman with Fahr’s disease who had reduced uptake in the striatum on both visual and quantitative assessment of 123I-Ioflupane SPECT images. The striatal involvement was asymmetric, despite the presence of substantially symmetric calcifications on CT and MRI.

Original languageEnglish
JournalClinical Nuclear Medicine
VolumePublish Ahead of Print
DOIs
Publication statusPublished - 20 Nov 2025
Externally publishedYes

Bibliographical note

Publisher Copyright:
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

Keywords

  • Fahr’s disease
  • I-Ioflupane SPECT
  • basal ganglia calcifications

Fingerprint

Dive into the research topics of 'Visual and Quantitative Analysis of 123I-Ioflupane SPECT Reveals Asymmetric Neuronal Degeneration in Fahr’s Disease'. Together they form a unique fingerprint.

Cite this